Mesenchymal stromal cells and fibroblasts: a case of mistaken identity?

被引:123
作者
Hematti, Peiman [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
关键词
HUMAN-BONE-MARROW; STEM-CELLS; INTERFERON-GAMMA; STEM/PROGENITOR CELLS; INTERNATIONAL-SOCIETY; IN-VITRO; DIFFERENTIATION; TISSUES; REPAIR; TRANSDIFFERENTIATION;
D O I
10.3109/14653249.2012.677822
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The plastic-adherent fibroblast-looking cells that can be isolated and culture-expanded from bone marrow and many other tissues are widely known as mesenchymal stromal cells (MSC). In addition to their fibroblast-like morphology, they are characterized by a panel of cell-surface markers and their potential to differentiate into bone, fat and cartilage. Based on their intriguing immunomodulatory and regenerative properties, MSC are being investigated as cellular therapeutics for a variety of clinical indications. However, many questions regarding the true identity and functionality of these cells in vivo remain unanswered. Fibroblasts, known for a much longer time but still poorly characterized, are also considered to be a ubiquitous stromal element of almost all tissues and are believed to play a role in tissue homeostasis. Despite the presence of MSC and fibroblasts in almost all tissues, similar morphology and other shared characteristics, the exact relationship between MSC and fibroblasts has remained undetermined. In this review, based on recent and old, but often neglected, literature it is suggested that ex vivo culture-expanded MSC and fibroblasts are indistinguishable by morphology, cell-surface markers, differentiation potential and immunologic properties.
引用
收藏
页码:516 / 521
页数:6
相关论文
共 66 条
[31]   Heterogeneity of mesenchymal stromal cell preparations [J].
Ho, A. D. ;
Wagner, W. ;
Franke, W. .
CYTOTHERAPY, 2008, 10 (04) :320-330
[32]   How do mesenchymal stromal cells exert their therapeutic benefit? [J].
Horwitz, E. M. ;
Dominici, M. .
CYTOTHERAPY, 2008, 10 (08) :771-774
[33]   Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [J].
Horwitz, EM ;
Prockop, DJ ;
Fitzpatrick, LA ;
Koo, WWK ;
Gordon, PL ;
Neel, M ;
Sussman, M ;
Orchard, P ;
Marx, JC ;
Pyeritz, RE ;
Brenner, MK .
NATURE MEDICINE, 1999, 5 (03) :309-313
[34]   Clarification of the nomenclature for MSC: The international society for cellular therapy position statement [J].
Horwitz, EM ;
Le Blanc, K ;
Dominici, M ;
Mueller, I ;
Slaper-Cortenbach, I ;
Marini, FC ;
Deans, RJ ;
Krause, DS ;
Keating, A .
CYTOTHERAPY, 2005, 7 (05) :393-395
[35]   The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells [J].
Jones, Simon ;
Horwood, Nicole ;
Cope, Andrew ;
Dazzzi, Francesco .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :2824-2831
[36]   Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages [J].
Kim, Jaehyup ;
Hematti, Peiman .
EXPERIMENTAL HEMATOLOGY, 2009, 37 (12) :1445-1453
[37]   Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy [J].
Koç, ON ;
Gerson, SL ;
Cooper, BW ;
Dyhouse, SM ;
Haynesworth, SE ;
Caplan, AI ;
Lazarus, HM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :307-316
[38]   MODULATION OF LYMPHOCYTE MITOGEN RESPONSES BY COCULTURED FIBROBLASTS [J].
KORN, JH .
CELLULAR IMMUNOLOGY, 1981, 63 (02) :374-384
[39]   Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells [J].
Krampera, Mauro ;
Cosmi, Lorenzo ;
Angeli, Roberta ;
Pasini, Annalisa ;
Liotta, Francesco ;
Andreini, Angelo ;
Santarlasci, Veronica ;
Mazzinghi, Benedetta ;
Pizzolo, Giovanni ;
Vinante, Fabrizio ;
Romagnani, Paola ;
Maggi, Enrico ;
Romagnani, Sergio ;
Annunziato, Francesco .
STEM CELLS, 2006, 24 (02) :386-398
[40]  
LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557